These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 8980014

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Protection after transient focal cerebral ischemia by the N-methyl-D-aspartate antagonist dextrorphan is dependent upon plasma and brain levels.
    Steinberg GK, Kunis D, Saleh J, DeLaPaz R.
    J Cereb Blood Flow Metab; 1991 Nov; 11(6):1015-24. PubMed ID: 1939379
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Neuroprotective efficacy and therapeutic window of the high-affinity N-methyl-D-aspartate antagonist conantokin-G: in vitro (primary cerebellar neurons) and in vivo (rat model of transient focal brain ischemia) studies.
    Williams AJ, Dave JR, Phillips JB, Lin Y, McCabe RT, Tortella FC.
    J Pharmacol Exp Ther; 2000 Jul; 294(1):378-86. PubMed ID: 10871336
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Protection against ischaemic neuronal damage by drugs acting on excitatory neurotransmission.
    Meldrum B.
    Cerebrovasc Brain Metab Rev; 1990 Jul; 2(1):27-57. PubMed ID: 2169834
    [Abstract] [Full Text] [Related]

  • 9. L-687,414, a low efficacy NMDA receptor glycine site partial agonist in vitro, does not prevent hippocampal LTP in vivo at plasma levels known to be neuroprotective.
    Priestley T, Marshall GR, Hill RG, Kemp JA.
    Br J Pharmacol; 1998 Aug; 124(8):1767-73. PubMed ID: 9756395
    [Abstract] [Full Text] [Related]

  • 10. Neuroprotective effect of D-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid in the gerbil model of transient global cerebral ischemia.
    Okada M, Ueda H, Kometani M, Nakao K, Kohjimoto Y, Takahashi I, Tanaka I.
    Arzneimittelforschung; 1997 Jun; 47(6):700-2. PubMed ID: 9239445
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Neuroprotective effect of NMDA receptor glycine recognition site antagonism persists when brain temperature is controlled.
    Takaoka S, Bart RD, Pearlstein R, Brinkhous A, Warner DS.
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):161-7. PubMed ID: 9040495
    [Abstract] [Full Text] [Related]

  • 17. Bis(7)-tacrine, a promising anti-Alzheimer's dimer, affords dose- and time-dependent neuroprotection against transient focal cerebral ischemia.
    Zhao Y, Li W, Chow PC, Lau DT, Lee NT, Pang Y, Zhang X, Wang X, Han Y.
    Neurosci Lett; 2008 Jul 11; 439(2):160-4. PubMed ID: 18515007
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. mGluR1 antagonist decreases tyrosine phosphorylation of NMDA receptor and attenuates infarct size after transient focal cerebral ischemia.
    Murotomi K, Takagi N, Takayanagi G, Ono M, Takeo S, Tanonaka K.
    J Neurochem; 2008 Jun 11; 105(5):1625-34. PubMed ID: 18248625
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.